Issels Integrative Immuno-Oncology March 9, 2017  

Tobacco Use Still Dominates As a Cause of Cancer

Dear Friend,

Thanks to wide-spread education about the dangers of tobacco use, smoking is at an all-time low in the United States. Despite this, tobacco is still linked to 40 percent of all cancer diagnoses, and these cases are not limited to just lung cancer.

Tobacco Use Continues to Be a High Risk Factor for Cancer

Disturbing information was reported in a recent article from the Centers for Disease Control and Prevention. Tom Frieden, director of the CDC, stated that nearly half of the country's 36 million smokers could die from tobacco-related diseases.

Of those 18 million potential fatalities, one-third is projected to come from cancer. Smoking is generally connected with lung cancer, but tobacco use is also tied to cancer in the throat, liver, pancreas, stomach, and eight other parts of the body.

Good News about Tobacco Use

A separate report issued by the CDC detailed the progress that's been made in reducing cigarette smoking. In the 10-year period between 2005 and 2015, smoking among adults dropped from 45.1 million to 36.5 million for a change of more than five percentage points.

Reduction in tobacco use has not occurred across the board. Males, especially African-Americans, still account for a high proportion of smokers, while groups such as the low-income and less-educated have the highest smoking rates.

Cancer Treatment Is Not One-Size-Fits-All

Each cancer diagnosis arises from a unique combination of factors that can include lifestyle choices, such as smoking along with heredity and environment. Our immunotherapy for cancer treatments are designed to meet the specific needs of your case. Contact us to learn why Issels® is the leader in state-of-the-art immunotherapy for cancer.

Tobacco Use Still Dominates As a Cause of Cancer

Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »

Study Finds that Older Lung Cancer Patients May Still Benefit from Surgery

In October, the Journal of Clinical Oncology published a study headed up by Dr. Prasad Adusumilli, a thoracic surgeon at Memorial Sloan Kettering Cancer Center in New York. Participants included more than 2,000 patients diagnosed with Stage 1 non-small cell lung cancer. Approximately 70 percent of the subjects were 65 or older. After these patients had surgery to remove the tumors, the group experienced a remarkable track record of success. Even more encouraging news was that after five years nearly 90 percent of the patients were alive and cancer-free.

Get the Full Story!

New Research: Melanoma Drug Causes Decrease in Lung Cancer Tumors

As reported in May in the New England Journal of Medicine, a recent study found that nivolumab (Opdivo), a new immune checkpoint inhibitor drug that reveals cancer cells that pretend to be healthy cells to help push the immune system to destroy the cancer, is stopping the spread of melanoma and lung cancers almost two times better than ipilimumab (Yervoy).

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:

Google +

Contact Info:

Phone: 888-447-7357


Treatments | Testimonials | Contact Us